Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Marrone Bio Innovations, Inc. (MBII) To Contact The Firm
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Marrone Bio Innovations, Inc. (“Marrone” or the “Company”) (NASDAQ: MBII) of the November 4, 2014 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit filed against Marrone and certain executives.
A complaint has been filed in the Eastern District of California on behalf of all persons who purchased or otherwise acquired Marrone securities between March 6, 2014 through September 2, 2014, inclusive (the “Class Period”).
The complaint alleges that the Company and its executives violated federal securities laws with respect to its disclosures concerning its business, operations, and prospects.
Specifically, the action alleges that during the Class Period, Marrone made false and/or misleading statements and/or failed to disclose that: (i) there were errors regarding improper revenue recognition in the Company’s financial statements; and (ii) Marrone did not employ adequate internal controls concerning its financial reporting.
On September 3, 2014, the Company disclosed that, among other things, some of its previously issued financial statements should no longer be relied upon as being compliant with generally accepted accounting principles.
Following this news, the price of Marrone stock declined by $2.50, or over 44%, to close at $3.15 on September 3, 2014.
If you invested in Marrone stock or options between March 6, 2014 through September 2, 2014, and would like to discuss your legal rights, you can contact us by calling Richard Gonnello toll free at 877-247-4292 or at 212-983-9330 or by sending an e-mail to email@example.com. Faruqi & Faruqi, LLP also encourages anyone with information regarding Marrone’s conduct to contact the firm, including whistleblowers, former employees, shareholders and others.
Richard W. Gonnello
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330
If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.